Number of the records: 1
BNT162b5
Subject h. BNT162b5 Subject h. BNT162b5 Entry terms COVID-19 vakcína Pfizer-BioNTech, bivalentná
Pfizer-BioNTech COVID-19 vakcína, bivalentnáEnglish X references COVID-19 Vaccine Pfizer-BioNTech, Bivalent
Pfizer-BioNTech COVID-19 Vaccine, BivalentScope note in English A combined mRNA vaccine, developed by Pfizer and BioNTech against SARS-CoV-2 with a mixture of the original strain of SARS-CoV-2 and BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2. 
subject heading
Number of the records: 1